The aryl hydrocarbon receptor: Differential contribution to T helper 17 and T cytotoxic 17 cell development

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Hayes, Mark D ^a   Ovcinnikovs, Vitalijs ^a   Smith, Andrew G ^b   Kimber, Ian ^a   Dearman, Rebecca J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; INTERLEUKIN 17; INTERLEUKIN 22; AHR PROTEIN, MOUSE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE EXPRESSION; GENOTYPE; HUMAN; IN VITRO STUDY; LYMPHOCYTE SUBPOPULATION; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN SECRETION; TH17 CELL; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DEFICIENCY; FEMALE; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; KINETICS; MALE; METABOLISM;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; FEMALE; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; INTERLEUKIN-17; INTERLEUKINS; KINETICS; MALE; MICE; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; TH17 CELLS;

EID: 84928497841     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106955     Document Type: Article

References (43)

1. Cerwenka A, Carter LL, Reome JB, Swain SL, Dutton RW (1998) In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J Immunol 161: 97-105.
2. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, et al. (1997) Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159: 105-17.
3. Waite JC, Skokos D (2012) Th17 response and inflammatory autoimmune diseases. Int J Inflam 2012: 819467.
4. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129: 1339-50.
5. Brand S (2009) Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58: 1152-67.
6. Hirota K, Ahlfors H, Duarte JH, Stockinger B (2012) Regulation and function of innate and adaptive interleukin-17-producing cells. EMBO Reports 13: 113-20.
7. Sonnenberg GF, Fouser LA, Artis D (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12: 383-90.
8. Hwang SY, Kim JY, Kim KW, Park MK, Moon Y, et al. (2004) IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NFkappaB- And PI3-kinase/Akt-dependent pathways. Arthritis Res Ther 6: R120- R8.
9. Beklen A, Ainola M, Hukkanen M, Gurgan C, Sorsa T, et al. (2007) MMPs, IL- 1, and TNF are regulated by IL-17 in periodontitis. J Dent Res 86: 347-51.
10. Kourilsky P, Truffa-Bachi P (2001) Cytokine fields and the polarization of the immune response. Trends Immunol 22: 502-9.
11. Hamada H, Garcia-Hernandez MeL, Reome JB, Misra SK, Strutt TM, et al. (2009) Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 182: 3469-81.
12. Yen HR, Harris TJ, Wada S, Grosso JF, Getnet D, et al. (2009) Tc17 CD8 T cells: functional plasticity and subset diversity. J Immunol 183: 7161-8.
13. Hu Y, Ma DX, Shan NN, Zhu YY, Liu XG, et al. (2011) Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia. PLoS One 6: e26522.
14. Hamada H, Bassity E, Flies A, Strutt TM, Garcia-Hernandez MeL, et al. (2013) Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J Immunol 190: 296-306.
15. Eysteinsdó ttir JH, Sigurgeirsson B, Olafsson JH, Frioriksson T, Agnarsson BA, et al. (2013) The role of Th17/Tc17 peripheral blood T cells in psoriasis and their positive therapeutic response. Scand J Immunol 78(6): 529-37.
16. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al. (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12: U255- U95.
17. Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, et al. (2010) Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol 185: 2089-98.
18. Bettelli E, Korn T, Kuchroo VK (2007) Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 19: 652-7.
19. McGeachy MJ, Cua DJ (2008) Th17 cell differentiation: the long and winding road. Immunity 28: 445-53.
20. Ko HP, Okino ST, Ma Q, Whitlock JP (1996) Dioxin-induced CYP1A1 transcription in vivo: the aromatic hydrocarbon receptor mediates transactivation, enhancer-promoter communication, and changes in chromatin structure. Mol Cell Biol 16: 430-6.
21. Ho PP, Steinman L (2008) The aryl hydrocarbon receptor: A regulator of Th17 and Treg cell development in disease. Cell Res 18: 605-8.
22. Denison MS, Nagy SR (2003) Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 43: 309-34.
23. Harper PA, Riddick DS, Okey AB (2006) Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 72: 267-79.
24. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, et al. (2008) The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453: 106-9.
25. Bachmann MF, Wolint P, Schwarz K, Jager P, Oxenius A (2005) Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol. 175: 4686-96.
26. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B (2009) Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 206: 43-9.
27. Kerkvliet NI, Shepherd DM, Baecher-Steppan L (2002) T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2, 3, 7, 8-tetrachlorodibenzo- p-dioxin (TCDD): AhR expression in both CD4 + and CD8 + T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD. Toxicol Appl Pharmacol 185(2): 146-152.
28. Evans BR, Karchner SI, Franks DG, Hahn ME (2005) Duplicate aryl hydrocarbon receptor repressor genes (ahrr1 and ahrr2) in the zebrafish Danio rerio: structure, function, evolution, and AHR-dependent regulation in vivo. Arch Biochem Biophys 441: 151-67.
29. Hu W, Sorrentino C, Denison MS, Kolaja K, Fielden MR (2007) Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro. Mol Pharmacol 71: 1475-86.
30. Oberg M, Bergander L, Hakansson H, Rannug U, Rannug A (2005) Identification of the tryptophan photoproduct 6-formylindolo[3, 2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol Sci 85: 935-43.
31. Rannug U, Rannug A, Sjöberg U, Li H, Westerholm R, et al. (1995) Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol 2: 841-5.
32. Zhang N, Agbor LN, Scott JA, Zalobowski T, Elased KM, et al. (2010) An activated renin-angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice. Biochem Pharmacol 80: 197-204.
33. Davies R, Clothier B, Robinson SW, Edwards RE, Greaves P, et al. (2008) Essential role of the AH receptor in the dysfunction of heme metabolism induced by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol 21: 330-40.
34. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T (2008) Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci U S A 105: 9721-6.
35. Bending D, De la Peña H, Veldhoen M, Phillips JM, Uyttenhove C, et al. (2009) Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 119: 565-72.
36. Satoh T, Tajima M, Wakita D, Kitamura H, Nishimura T (2012) The development of IL-17/IFN-c-double producing CTLs from Tc17 cells is driven by epigenetic suppression of Socs3 gene promoter. Eur J Immunol 42: 2329-42.
37. McArthur MA, Sztein MB (2012) Heterogeneity of multifunctional IL-17A producing S. Typhi-specific CD8+ T cells in volunteers following Ty21a typhoid immunization. PLoS One 7: e38408.
38. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, et al. (2008) Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.
39. Zhang L, Ma J, Takeuchi M, Usui Y, Hattori T, et al. (2010) Suppression of experimental autoimmune uveoretinitis by inducing differentiation of regulatory T cells via activation of aryl hydrocarbon receptor. Invest Ophthalmol Vis Sci 51: 2109-17.
40. Di Meglio P, Duarte JH, Muller H, Hirota K, Nestle FO, et al. (2012) The Aryl hydrocarbon receptor modulates psoriasis-like skin inflammation. J Invest Dermatol 132: S14-S35.
41. Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, et al. (2009) A Th17- like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity. Eur J Immunol 39: 1716-25.
42. Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, et al. (2013) IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 123: 247-60.
43. Henriques A, Gomes V, Duarte C, Pedreiro S, Carvalheiro T, et al. (2013) Distribution and functional plasticity of peripheral blood Th(c)17 and Th(c)1 in rheumatoid arthritis. Rheumatol Int 33: 2093-9.